CloudMD Software & Services Inc. (V:DOC)
Business Focus: Software (NEC)
| Sector: Technology | Industry: Software |
| Company Contact | |
| Address: | 2200 HSBC Building 885 West Georgia Street VANCOUVER BC V6C 3E8 |
| Tel: | N/A |
| Website: | https://investors.cloudmd.ca |
| IR: | See website |
| Key People | ||
| Karen Adams President, Chief Executive Officer, Chief Operating Officer, Director | John Plunkett Chief Financial Officer | Amit Mathur Director, President - US Operations |
| Bram Lowsky Executive Vice President - Head of Health and Wellness | Robin Cooper Senior Vice President - Partnerships and Growth | Eric Lalonde Senior Vice President - Customer Success and Growth |
| Angel Paravicini Senior Vice President - Business Development and Customer Success | Dhruv Chandra Chief Technology Officer | Mena Beshay Global Head, Corporate Development |
| Business Overview |
| CloudMD Software & Services Inc. is a healthcare service provider. The Company operates through two divisions: Health and Wellness Services (HWS) and Health and Productivity Solutions (HPS). HWS operates through two models: subscription-based pricing using a price per member per month with an average contractual term of three years; and a per-case billing model at an agreed-upon rate for services that are used in disability management, occupational health, and other employer services. HPS division offers health and productivity tools intended to create a better experience for those needing healthcare. The Company's workplace health and wellbeing solution, Kii, supports members and their families with a personalized and connected healthcare experience across mental, physical and occupational health. Kii delivers superior clinical health outcomes, consistent high engagement, and measurable ROI for payers such as employers, educational institutions, associations, governments and insurers. |
| Financial Overview |
| For the six months ended 30 June 2023, CloudMD Software & Services Inc revenues decreased 20% to C$46.1M. Net loss before extraordinary items decreased 28% to C$11.7M. Revenues reflect Health and Wellness Services segment decrease of 15% to C$42.9M, Health and Productivity Solutions segment decrease of 5% to C$6.4M, Canada segment decrease of 17% to C$40.3M. Lower net loss reflects Acquisition and divestiture-related. |
| Employees: | 224 as of Dec 31, 2020 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $38.43M as of Jun 30, 2023 |
| Annual revenue (TTM): | $99.45M as of Jun 30, 2023 |
| EBITDA (TTM): | -$6.55M as of Jun 30, 2023 |
| Net annual income (TTM): | -$115.32M as of Jun 30, 2023 |
| Free cash flow (TTM): | -$16.56M as of Jun 30, 2023 |
| Net Debt Last Fiscal Year: | $6.23M as of Jun 30, 2023 |
| Shares outstanding: | 302,505,970 as of Sep 19, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2023 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.